Chairperson:

Reginald E. Smith
Pharm.D. ACPR
Current Position(s):
Clinical Specialist, Cardiac Services & Thrombosis Clinic
Clinical Researcher
Clinical Instructor, Faculty of Medicine, UBC (IMP)
Clinical Instructor, Faculty of Pharmaceutical Science UBC
Adjunct Associate Professor of Nursing, University of Victoria

Practice Site :
Royal Jubilee Hospital & Victoria Heart Institute, Victoria, B.C.

Practice Expertise and Interests:
Anticoagulation
Venous Thromboembolism,
Coronary Care Unit,
Heart Cath Lab
EP Lab
Cardiac Surgery

Research :
Venous Thromboembolism & Antithrombotic Therapies

Email:reginald.smith@viha.ca
Reginald E. Smith, Pharm.D. , ACPR
Clinical Specialist,
Cardiovascular Medicine & Thrombosis Clinic
Royal Jubilee Hospital & Victoria Heart Institute
Victoria, B.C

Reg Smith is a Clinical Specialist in Cardiovascular Medicine & Thrombosis at the Royal Jubilee Hospital (RJH) in Victoria, BC, and a Clinical Researcher at the Victoria Heart Institute.

Dr. Smith operates the thromboembolism clinic at the Royal Jubilee Hospital and oversees numerous clinic visits per year for venous and arterial thromboembolism. His cardiology practice includes a heart catheterization lab and a high volume electrophysiology lab.

He obtained his B.Sc.(Pharm) from U.B.C. and his hospital residency at Burnaby Hospital, then after working in Saudi Arabia completed his Pharm.D. at the University of Kentucky.

Dr. Smith has been a principle or co-investigator in numerous cardiovascular clinical trials. He is an active member of the Canadian Cardiovascular Society (CCS) and is also member of the Thrombosis Interest Group of Canada (TIGC).

Dr. Smith is an instructor in the Faculty of Medicine, Island Medical Program, University of Victoria and the Faculty of Pharmaceutical Sciences at the University of British Columbia. He is an Adjunct Associate Professor of Nursing at the University of Victoria.

Chairperson-Elect:

Sheri L. Koshman
BScPharm, PharmD, ACPR
Current Position(s):
Assistant Professor of Medicine, University of Alberta

Practice Site:
Cardiac EASE Clinic
Cardiovascular Risk Reduction Clinic
Heart Function Clinic at the Mazankowski Alberta Heart Institute

Practice Expertise and Interests:
Ambulatory cardiology, risk reduction, heart failure, medication adherence

Email:sheri.koshman@ualberta.ca

Chairperson-Past:

Yana Shamiss
Pharm D. CDE, RPh
Current Position(s):
Pharmacy Clinical Education/
Pre-Op and Anticoagulation Clinic Pharmacist

Practice Site :
Southlake Regional Health Center
Newmarket, Ontario

Practice Expertise and Interests :
Anticoagulation management in the ambulatory care setting
Pre-operative cardiovascular care and preoperative risk reduction
Acute care cardiology

Research Interests :
Atrial fibrillation
Prevention strategies
Cost implication in care
Risk stratification of ACS patients

Treasurer:

Travis Warner
BSP, ACPR, BCPS
Current Position(s):
Clinical Pharmacist, Cardiac Sciences Program
St. Boniface Hospital, Winnipeg, MB

Practice Site :
Inpatient Cardiology
Coronary Care Unit
Cardiothoracic Surgery Intensive Care
Medical/Surgical Intensive Care

Practice Expertise and Interests :
Acute coronary syndromes
Heart failure
General inpatient cardiology
Clinical practice tools

Email: twarner@sbgh.mb.ca

Strategic Partner Liason:

William Semchuk
BSP, MSc, PharmD, FCSHP
Current Position(s) :
Manager, Clinical Pharmacy Services, Regina Qu’Appelle Health Region
Manager, Regina Lipid Clinic, Regina Qu’Appelle Health Region
Assistant Clinical Professor, College of Pharmacy and Nutrition, University of Saskatchewan
Assistant Clinical Professor, College of Medicine, University of Saskatchewan
Adjunct Professor, Faculty of Graduate Studies, University of Regina

Practice Site :
Regina Qu’Appelle Health Region

Practice Expertise and Interests :
Cardiovascular Risk Reduction
• Dyslipidemia
• Hypertension
• Smoking
• Diabetes
• Cardiac Rehabilitation
Acute Cardiology
• Member of Open heart surgical care team
Thrombosis
• VTE Prevention

Research:
• Care Gaps and Models to close care gaps
• Quality Improvement

E- mail:Bill.Semchuk@rqhealth.ca
Academic Background:

Doctor of Pharmacy
Purdue University
West Lafayette, IN.

M. Sc. Clinical Pharmacy
University of Saskatchewan
Saskatoon, Saskatchewan

Hospital Pharmacy Residency
University Hospital
Saskatoon, Saskatchewan

Bachelor of Science, Pharmacy
University of Saskatchewan
College of Pharmacy
Saskatoon, Saskatchewan

Articles Recently Published:

Semchuk W, Soutar T. Dietary intervention in dyslipidemia. CPJ 2008;141(Suppl 2):S19 – S20.

Pearson G, Thompson A, Semchuk W. Guidelines for the management of dyslpidemia and prevention of cardiovascular disease by pharmacists. CPJ 2008;141(Suppl 2):S11-S16.

Chan A, Campbell N, Lewanczuk R, Semchuk W, Thompson A, Tsuyukie R. 2008 Canadian hypertension education program guidelines for the management of hypertension by pharmacists. CPJ 2008;141(6):327-331.

Lamb D, Blackburn D, PausJenssen A, Semchuk W, Robertson P. Heart failure: Back to basics for pharmacists. CPJ 2008;141(1):48-57.

Evans C, Balackburn D, Semchuk W, Taylor JG. Collaborative cardiovascular risk-reduction in primary care: Design of the CCARP study. CPJ 2007;140(4):240-242.

Pearson G, Thompson A, Semchuk W. 2007 Guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists. CPJ 2007;140(6):383-388.

Taylor J, Semchuk W, Deschamps M, Tsuyuki R, Duffy P, Wilson T. A community based study of pharmacist involvement in the care of high risk cardiac patients – the PIRR study: The effect of two methods of pharmacist training. CPJ 2007;140(2):116-123.

Semchuk, W, Taylor J, Sulz L, Deschamps M, Tsuyuki R, Duffy P, Wilson T. Pharmacist intervention in risk reduction: the PIRR study. A community based study of pharmacist involvement in the care of high risk cardiac patients. CPJ 2007;140(1):32-37.

Webmaster:

Elaine Lum
BSc(Pharm), ACPR, PharmD, BCPS
Current Position(s):
Clinical Pharmacotherapeutic Specialist, Cardiology
Clinical Assistant Professor, Faculty of Pharmaceutical Sciences, University of British Columbia

Practice Site:
Cardiac Sciences, Vancouver General Hospital, Vancouver Coastal Health Authority, BC

Practice Expertise and Interests:
Acute coronary syndromes
Coronary Care Unit
General Inpatient Cardiology

Email: elaine.lum@vch.ca
Margaret L. Ackman
BSc(Pharm), PharmD, FCSHP
Current Position:
Clinical Practice Leader, Pharmacy Services
Alberta Health Services

Practice Site:
Coronary Care Unit, University of Alberta Hospital

Practice Expertise and Interests:
- Acute coronary syndromes
- Percutaneous coronary intervention
- Dual antiplatelet therapy
- Practice patterns

Email: margaret.ackman@albertahealthservices.ca
Lori Albers
B. Pharm, MSc(Pharm), PhD, BSP, ACPR
Current Position(s):
Clinical Coordinator, Department of Pharmacy Services, Regina Qu’Appelle Health Region, Regina, SK

Clinical Practice Areas:
Coronary Care Unit
Cardiac Surveillance Unit
Surgical Telemetry Unit

Practice Expertise and Interests:
General Inpatient Cardiology

E-mail: Lori.Albers@rqhealth.ca
Selected Publications:

TBA

Claudia Bucci
BScPhm, PharmD, ACPR
Current Position(s):
Clinical Coordinator, Cardiovascular Diseases
Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto

Practice Site:
Coronary Care Unit, Sunnybrook Health Sciences Centre

Practice Expertise and Interests:
Acute Coronary Syndromes
Practice Patterns and Outcomes

E-mail: claudia.bucci@sunnybrook.ca
Education:
Bachelor of Science in Pharmacy, Unviersity of Toronto
Doctor of Pharmacy Degree, Duquesne University, Pittsburgh, PA
Hospital Pharmacy Residency, Toronto General Hospital, University Health Network

Interests:
Acute Coronary Syndromes
Practice Patterns and Outcomes

Recent Publications/Abstracts:

Goodman S, Le May M, Lang E, Mathieu B, Morris S, Bucci C. ACS Management in the Emergency Department: Focus on Oral Antiplatelet Therapy. Elsevier Perspectives in Cardiology 2015 (March);Vol 1, Number 3.

AD Patel, MK Tan, P Angaran, AD Bell, M Berall, C Bucci et al. Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients: Insights from the CO-ordinated National Network to Engage physicians in the Care and Treatment of patients with Atrial Fibrillation (CONNECT AF). Am J Cardiology 2015;115(5):641-6.

Gandhi S, Zile B, Tan MK, Saranu J, Bucci C, et al. Increased Uptake of Guideline Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective. Can J Card 2014;30:1725-31.

Ackman M, Bucci C, Callaghan M et al. A Pharmacist’s Guide to the 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy. CPJ 2015;148(2):71-81.

Bucci C, Sinclair A, Geerts W, Fremes S. Efficacy and Safety of Low Molecular Weight Heparin Anticoagulation After Heart Valve Surgery. [Abstract] Can J Card 2008;24(Suppl SE).

Bucci C, Mamdani M, Juurlink D, Tu J. Dihydropyridine Calcium Channel Antagonists and Cardiovascular Outcomes in Elderly Patients: A Population-Based Study. Can J Card 2008;24(8):629-632.

Bucci C, Sinclair A, Tawfik S, Geerts W, Pahk M, Bartle B. Implementation and Evaluation of a Pharmacy-Based Heparin-Induced Thrombocytopenia Safety Improvement Initiative in Cardiac Surgery. [Abstract] CJHP 2007;60:(Suppl 1)S53.

Bucci C, Holbrook A, Bates S, Cyr M. Severe Thrombotic Reaction and Amputation Following Initiation of Celecoxib: A Case Report. [Abstract] Can J Clin Pharm 2006;13(2).

Bucci C, Oh P. Medication Utilization Rates After Acute Myocardial Infarction in a Cardiac Rehabilitation Population. [Abstract] CJHP 2006;59:(Suppl 1)S53.

Tammy J Bungard
BSP, PharmD
Current Position(s):
AMS Program Director
Associate Professor of Medicine (Cardiology)

Practice Site:
Anticoagulation Management Service (University of Alberta)
Stroke Prevention Clinic (University of Alberta)

Practice Expertise and Interests:
Thrombosis

Email: tammy.bungard@ualberta.ca
Douglas Doucette
BSc, PharmD, FCSHP
Current Position(s):
Regional Pharmacy Clinical Manager & Clinical Resource Pharmacist, Cardiology - Horizon Health Network, New Brunswick
Associate Professor, College of Pharmacy - Dalhousie University, Halifax, Nova Scotia

Practice Site:
Cardiac Rehabilitation Clinic, The Moncton Hospital, Horizon Health Network

Practice Expertise and Interests:
Practice-based and QI research projects in the areas of cardiology and diabetes including secondary prevention of coronary artery disease, VTE prevention, motivational interviewing and lifestyle change including adherence to drug therapy and smoking cessation.

Email:douglas.doucette@horizonnb.ca
Education:
BSc(Pharm), Dalhousie University, 1989
PharmD, University of Toronto, 1995

Teaching & Research Interests

Doug Doucette received his BSc in Pharmacy from Dalhousie University and Doctor of Pharmacy degree from the University of Toronto. He served more than 20 years as a Pharmacy Officer in the Canadian Forces in base clinics, military hospitals and medical supply depots across Canada and on overseas military operations in Bosnia and Afghanistan. During this period he provided pharmaceutical care to patients in adult intensive care units, surgery, trauma, neurosurgery, general medicine, ambulatory clinics and advance (field) surgical centres.

Upon retiring from the military in 2006, Doug joined the Moncton Hospital as Pharmacy Clinical Coordinator and Clinical Pharmacy Specialist in Cardiology. In 2009 he was appointed to his current position as Regional Pharmacy Clinical Manager, Pharmacy Services, Horizon Health Network in New Brunswick. Doug maintains a part-time clinical practice in cardiology/coronary care unit at the Moncton Hospital and has served as Principal Investigator in a number of applied research projects in the areas of cardiology, diabetes, and pharmacy practice. In 2007 he was recognized by the New Brunswick Department of Health with the Clinical Champion Award for his multidisciplinary work in diabetes management and is a member of the New Brunswick Diabetes Task Force. He is actively involved in a number of professional organizations as committee member, educator, lecturer and reviewer, and is a Fellow of the Canadian Society of Hospital Pharmacists. Doug represents the Atlantic region on Editoral Board of the Hospital Pharmacy in Canada Report and is Chairperson (2011-2012) of the Canadian Cardiovascular Pharmacists’ Network.

Recent publications:

Gould, O., Buckley, P., & Doucette, D. What patients want: preferences regarding hospital pharmacy services. (manuscript in progress)

Doucette D. Update on statin adverse effects. Pharm Pract 2012 (scheduled for release in July)

Doucette, D., Goodine, C., Symes, J., Clarke, E., & Simpson, S. Patient recall of interaction with a pharmacist during hospital admission. Can J Hosp Pharm 2012; 65:58 (abstract & poster presentation at Canadian Society of Hospital Pharmacists Professional Practice Conference 2012).

Doucette D. Should key performance indicators for clinical services be mandatory? The “Pro” side. Can J Hosp Pharm 2011;64:55-56.

Doucette D. Pharmacist Primer on Management of Patients Post-Myocardial Infarction. Pharm Pract 2009 Oct.

Recent presentations:

Jun 8, 2012 - What patients want: preferences regarding hospital pharmacy services. Dr. MacLellan Research Day, Moncton, NB

May 24, 2012 - RichardA.MerrettMemorialLecture:Development of National Clinical Pharmacy Key Performance Indicators: Stakeholder Consultation (Workshop co-facilitated with Dr. Sean Gorman). Maritime Provinces Hospital Pharmacy Management Seminar, Pictou Lodge, NS

Apr 28, 2012 - Patient Assessment (Smoking Cessation) Pearls Workshop / What’s New in Lipids. Contemporary Therapeutic Issues in Cardiovascular Disease, Toronto, ON

Oct 1, 2011 - Beyond statins (workshop). Canadian Cardiovascular Pharmacists’ Network Atlantic Fall Symposium, Dartmouth, NS

Feb 2012 - Patient recall of interaction with a pharmacist during hospital admission. Canadian Society of Hospital Pharmacists. Virtual poster session, Feb 2012. Accessed at http://www.cshp.ca/programs/cshp2015/virtualPosters/poster_4.html

August 7, 2011 - Leadership pearls: Danny Ocean - Inspirational leader, or common criminal? Canadian Society of Hospital Pharmacists Summer Education Sessions, Vancouver, BC

August 8, 2011 - Measuring pharmacy's worth (co-presented with Bruce Millin). Canadian Society of Hospital Pharmacists Summer Education Sessions, Vancouver, BC

October 2, 2010 - Insulin in Inpatients: An Interactive Workshop. Canadian Cardiovascular Pharmacists’ Network Atlantic Fall Symposium, Dartmouth, NS

August 8, 2010 - Applying the STEMI Guidelines to Different Types of Hospitals (co-presented with Dr.Heather Kertland). Canadian Society of Hospital Pharmacists Summer Education Session, Halifax, NS

Andrea Kent
BScPharm, PharmD
Current Position:
Manager of Pharmacy Services at Nova Scotia Health Authority – Colchester Site;

Practice Site:
ICU/CCU, Colchester East Hants Health Authority, Truro, NS

Practice Expertise and Interests:
Cardiology
Drug Utilization
Policy Change

Email: Andrea.Kent@nshealth.ca
Current Position:
Clinical Co-ordinator / DUE, Colchester East Hants Health Authority, Truro, Nova Scotia
Adjunct Professor, College of Pharmacy, Dalhousie University, Halifax, Nova Scotia.
Clinical practice area – ICU/CCU

Education:
Bachelor of Science in Pharmacy Dalhousie University, Halifax, Nova Scotia
Doctor of Pharmacy (PharmD) Idaho State University, Pocatello, Idaho

Research and Practice Interests:
Cardiology and Drug Utilization and Policy Change

Presentations:

Oct 2008
Pain Management in the Elderly. Atlantic Provinces Inter-Professional Pain Conference. Halifax, NS

May 2007
Warfarin verses ASA: Pick your Poison. Canadian Therapeutics Congress, Halifax NS

Oct 2006
Atrial Fibrillation: Rate versus Rhythm Control. Contemporary Issues in Cardiovascular Disease Conference. Halifax, NS

May 2006
CHARISMA Trial. Joint Therapeutics Congress, Toronto, ON

April/May 2006
AACT (Addressing Additional Cardiovascular Risk Factors) in Hypertension. Glengarry, Truro NS and Glasgow Square, New Glasgow, NS.

April/May 2006
NSAIDs and the Arthritis Patient. Ramada Inn, Halifax, NS and Heather Hotel, Stellarton, NS

Oct 2005
Lead with the Facts: Health Canada’s Position on Coxibs and NSAIDs – Where do we go from here? Maritime Fall Refresher Symposium, Halifax, NS and St John’s Nfld.

May 2005
COX-2 Inhibitors – Behind the Headlines. CSHP Nova Scotia Branch AGM, Halifax, Nova Scotia

June 2003
Improving Cardiovascular Outcomes in Nova Scotia (ICONS) – Acute Coronary Syndrome Management. Cambridge Suites, Sydney, Nova Scotia and Howard Johnson’s, Truro, Nova Scotia.

Feb 2003
Medication Use in CHF – A review of the Evidence. Museum of Industry, Stellarton, Nova Scotia

Heather Kertland
BScPhm, PharmD
Current Position(s):
Clinical Pharmacy Specialist/Leader – Heart and Vascular Program , St Michael’s Hospital
Assistant Professor (status only), Leslie Dan Faculty of Pharmacy, University of Toronto

Practice Site:
Coronary Care Unit, St Michael’s Hospital, Toronto, ON

Practice Expertise and Interests:
Acute Care Therapeutics
Arrhythmia Management
Quality and outcomes

Email:kertlandh@smh.ca
Current Position
Clinical Pharmacy Specialist/Leader – Heart and Vascular Program/Research/DUE, Department of Pharmacy
St Michael’s Hospital
Assistant Professor
Leslie L Dan Faculty of Pharmacy
University of Toronto

Contact Info:
Department of Pharmacy
St Michael’s Hospital
30 Bond Street, Toronto, ON
M5B 1W8
Phone: (416) 864-5427
Fax: (416) 864-6058
E-mail: kertlandh@smh.toronto.on.ca

Past Position:
Director, Doctor of Pharmacy Programme
(March 08 - Rhodes University January 09)
Grahamstown, South Africa

Education:
Fellowship, Cardiovascular Therapeutics
Hartford Hospital
Hartford, Connecticut

Doctor of Pharmacy
Wayne State University
Detroit, Michigan

Pharmacy Practice Residency
McMaster University Medical Centre
Hamilton, Ontario

Bachelor of Science in Pharmacy
University of Toronto
Toronto, Ontario

Recent Publications:

Articles:

Yan AT, Yan RT, Tan M, Hackman DG, Leblanc KL, Kertland H, et al Contemporary Management of dyslipidemia in High Risk patients: Targets Still Not Met Am J Med 2006;119:676-83.

Fitchett DH, Borgundvaag B, Cantor W, Cohen E, Dhingra S, Fremes S, Gupta M, Hefferman M, Kertland H, Husain M, Langer A, Letovsky E, Goodman SG for the Renewal of the NonSTE ACS algorithm group Non-ST segment elevation acute coronary syndromes: A simplified risk-oriented algorithm Can J Cardiol 2006;22

Kertland H. Keeping the Beat Pharmacy Practice September 2004

Kwok L, Kertland H Antiplatelet agents in Cardiovascular Disease Pharmacy Practice (CE Lesson) May 2004

Paradiso-Hardy F, Gordon W, Jackevicius C, Kertland H, Pearson F, Pickering J et al The Importance of In-Hospital Statin Therapy for Patients with Acute Coronary Syndromes Pharmacotherapy 2003:23:506-513.

Abstracts:

Njuguna CW, Kertland H, Parrish A. Drug Utilization Evaluation (DUE): Are we using warfarin in the safest manner? SAAHIP 2009

Munsamy JL, Parish A, Kertland H validation of a fixed-dose, weight adjusted, subcutaneous unfractionated heparin for acute treatment of venous thromboembolism SAAHIP 2009

Singh S, Kertland H Role of the pharmacist as a team leader for total parenteral nutrition in a south African tertiary hospital complex SAAHIP 2009

Brown TER, Chant C, Dresser L, Einarson T, Kertland H Comparison of student course evaluations between a Full-time and Part-time Doctor of Pharmacy Program AJPE 2008;72:61

Chant C, Dresser L, Kertland H, Brown TER Webcam utilization in a part-time Distance-Learning Doctor of Pharmacy Program AJPE 2008;72:81

Lail S, Jeffrey J, Bhojwani R, Fitchett D, Kertland H Root Cause Analysis for Major Bleeding in Patients with Acute Coronary Syndrome Pharmacotherapy 2008;

Research:

Barriers and Facilitators to obtaining an accurate Medication History – Coinvestigator MedBuy Endowment Fund $7500

Evaluation of Smoking Cessation Invertention Program Co-Investigator

The Accuracy of Patient Weights Used for the Dosing of Weight-Based Pharmacologic Agents in Acute Coronary Syndromes Co-investigator

Assessment of Pharmacist-delivered patient education at St Michael’s Hospital Principal investigator Funded by: Medbuy Endowment Fund $9,000

COMMITTEES/APPOINTMENTS

Reviewer - Canadian Journal of Hospital Pharmacy
CPhA - Editorial Review Panel e-Therapeutics 2005 -
Canadian Pharmacist’s Journal
Annals of Pharmacotherapy
Lancet
Pharmacotherapy

Canadian Cardiovascular Pharmacists Network
Member 1995 – present,
Chair 1998/99, 2006/07
Chair Elect 2005/06

AFFILIATIONS American College of Clinical Pharmacy
Association of Faculties of Pharmacy in Canada
Canadian College of Clinical Pharmacy
Canadian Cardiovascular Pharmacy Network
Canadian Cardiovascular Society
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Kori Leblanc
BScPhm, ACPR, PharmD
Current Position(s):
Cardiovascular Pharmacotherapy Specialist - Department of Pharmacy and Center for Innovation in Complex Care, University Health Network
Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto

Practice Site:
AFIB Innovation Program, Toronto General Hospital

Practice Expertise and Interests:
Congestive Heart Failure
Atrial Fibrillation
Pharmacy Practice

Email:kori.leblanc@uhn.ca
Ann-Marie
B.Sc.Phm. ACPR
Current Position(s):
Clinical Trials and Clinical Pharmacist, Cardiac Surgery

Practice Site:
Royal Columbian Hospital

Practice Expertise and Interests:
Cardiac Surgery, Anticoagulation, Research

Dr. Glen J. Pearson
BSc, BScPhm, PharmD, FCSHP
Current Position(s):
Associate Professor of Medicine, University of Alberta
Co-Director, Cardiac Transplant Clinic, Division of Cardiology, Mazankowski Alberta Heart Institute
Co-Medical Director and Director of Research, Cardiovascular Risk Reduction Clinic, Division of Cardiology, Mazankowski Alberta Heart Institute

Practice Site:
Cardiac Transplant Clinic, Mazankowski Alberta Heart Institute
Cardiovascular Risk Reduction Clinic, Mazankowski Alberta Heart Institute

Practice Expertise and Interests:
Heart Transplantation/Immunotherapy
Dyslipidemia
Comprehensive CV Risk Reduction
Cardiovascular Pharmacotherapy
CV Health Outcomes Research
General Cardiology

Email:Glen.Pearson@ualberta.ca
Current Position/Practice Site:
Associate Professor of Medicine
Co-Director, Cardiac Transplant Clinic
Co-Medical Director and Director of Research, Cardiovascular Risk Reduction Clinic
Division of Cardiology
Mazankowski Alberta Heart Institute
University of Alberta

Contact Information:
Suite 2C2 Walter C. Mackenzie Health Sciences Centre
8440 – 112th Street
Edmonton, Alberta
T6G 2B7

E-Mail: Glen.Pearson@ualberta.ca
Phone: (780)407-1590
Fax: (780)407-1496

Practice Expertise/Research Interests:
• Heart Transplantation/Immunotherapy
• Dyslipidemia
• Comprehensive CV Risk Reduction
• Cardiovascular Pharmacotherapy
• CV Health Outcomes Research
• General Cardiology

Selected Peer-Reviewed Publications:

1. Ostad N, Pearson GJ. Dual Antiplatelet Therapy for Cardiovascular Protection: Indication, Duration, and Other Considerations. Geriatrics & Aging 2009;12(4): 186-191.

2. Zuk DM, Pearson GJ. Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients—a systematic review. Transplantation Reviews 2009;23:171-177.

3. Mansell H, Pearson GJ. Macrolide Antibiotics and Calcineurin Inhibitors: Avoiding a Far Too Common Drug Interaction in Transplant Patients. Canadian Pharmacist Journal (CPJ) 2009;142(2):68-70.

4. Pearson GJ. Gaps, Goals and Getting to Target: A Call to Action for Pharmacists! (Guest Editorial). Canadian Pharmacist Journal (CPJ) 2008;141(Supplement 2):S6.

5. Pearson GJ, Thompson AE, Semchuk W. 2007 Guidelines for the Management of Dyslipidemia and Prevention of Cardiovascular Disease by Pharmacists. Canadian Pharmacist Journal (CPJ) 2008;141(Supplement 2):S11-S18.

6. Pearson GJ. Should Pharmacists Have Prescribing Privileges? The “Pro” Side. Can J Hosp Pharm 2008;61(5):351-2.

7. Pearson GJ, Olson KL, Panich NE, Tsuyuki RT, Majumdar S, Gilchrist DM, Damani A, Francis GA. Maintenance of Improved Lipid Levels Following Attendance at a Cardiovascular Risk Reduction Clinic – A 10-year experience. Vascular Health and Risk Management 2008;4(5):1127-1135.

8. Pearson GJ, Thompson AE, Semchuk W. 2007 Guidelines for the Management of Dyslipidemia and Prevention of Cardiovascular Disease by Pharmacists. Canadian Pharmacist Journal (CPJ) 2007:140(6):383-88.

9. Pearson GJ. Evolution in the Practice of Pharmacy – Not a Revolution!. CMAJ 2007;176:1295-96.

10. Chan M, Pearson GJ. New Advances in Anti-Rejection Therapy. Current Opinion in Cardiology 2007;22:117-22.

11. Burton JR, I Burton, Pearson GJ. Clopidogrel-Precipitated Rhabdomyolysis in a Stable Heart Transplant Patient. Ann Pharmacother 2007;41:133-37.

12. Pearson GJ, Francis GA, Romney JS, Gilchrist DM, Opgenorth A, Gyenes GT. Clinical Efficacy and Tolerability of Ezetimibe in High-Risk Patients Managed in a Specialty Cardiovascular Risk Reduction Clinic. Can J Cardiol 2006;22:939-45.

13. Meyer SR, Modry DL, Norris CM, Pearson GJ, Bentley MJ, Koshal A, Mullen JC, Rebeyka IM, Ross DB, Wang SH. Pre-Transplant Diabetes, Not Donor Age, Predicts Long-Term Outcomes in Cardiac Transplantation. J Card Surg 2006;21:117-124.

14. Koshman SL, Lalonde LD, Burton I, Tymchak WJ, Pearson GJ. Supra-therapeutic response to ezetimibe concomitantly administered with cyclosporine. Ann Pharmacother 2005;39(9):1561-5.

15. Yamada C, Johnson JA, Robertson P, Pearson GJ, Tsuyuki RT. Long Term Impact of a Community Pharmacist Intervention on Cholesterol Levels in Patients at High Risk for Coronary Heart Disease Events: The Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus) Extended Follow-up. Pharmacotherapy 2005;25(1):110-115.

16. Strachan D, Burton I, Pearson GJ. Is Oral Azithromycin Effective for the Treatment of Cyclosporine-Induced Gingival Hyperplasia in Cardiac Transplant Recipients? Journal of Clinical Pharmacy and Therapeutics 2003;28(4):329-338.

17. Pharand C, Ackman ML, Jackevicius C, Paradiso-Hardy FL, Pearson GJ, for the Canadian Cardiovascular Pharmacists Network (CCPN/RCPC). Use of OTC and Herbal Products in Patients with Cardiovascular Disease. Ann Pharmacother 2003;37(6):899-904.

18. Paradiso-Hardy FL, Gordon WL, Jackevicius CA, Kertland HR, Pearson GJ, Pickering JL, Poirier L, Semchuk WM, Verret L. The Importance of In-Hospital Statin Therapy for Patients with Acute Coronary Syndromes. Pharmacotherapy 2003;23(4)506-513.

19. Taher TH, Dzavik V, Reteff EM, Pearson GJ, Woloschuk BL, Francis GA. Tolerability of statin-fibrate and statin-niacin combination therapy in dylipidemic patients at high risk for cardiovascular events. Am J Cardiol 2002 Feb 15; 89(4):390-394.

20. Thompson AE, Hirsch GM, Pearson GJ. Assessment of New Onset Post-Coronary Artery Bypass Atrial Fibrillation: Current Practice Pattern Review and Development of Treatment Guidelines. J Clin Pharm Ther 2002;27(1):21-37.

21. Pearson GJ, Simmons WKT, Cooke CA, Sketris I. Evaluation of the Use of Evidence-Based Angiotensin-Converting Enzyme Inhibitor Criteria for the Treatment of Congestive Heart Failure: Opportunities for Pharmacists to Improve Patient Outcomes. J Clin Pharm Ther 2001;26(5):351-361.

Chantal Pharand
BPharm, PharmD, BCPS
Current Position(s):
Professor and Associate Vice-rector, Student Affairs and Success, Université de Montréal, Montréal, Qc Clinical Pharmacist Hôpital du Sacré-Coeur de Montréal, Montréal, Qc

Practice Site:
Risk Reduction Clinic, Hôpital du Sacré-Coeur de Montréal, Montréal, Qc

Practice Expertise and Interests:
Acute Coronary Syndromes, Coronary Care Unit, Risk Reduction Clinic

E-Mail: chantal.pharand@umontreal.ca
Academic Background:
Fellowship in Cardiovascular Pharmacology
Hôpital du Sacré-Coeur de Montréal and Université de Montréal, Montréal, Québec
Fellowship in Cardiovascular Therapeutics
Hartford Hospital, Hartford, Connecticut and University of Connecticut, School of Pharmacy, Storrs, Connecticut
Doctor of Pharmacy (Pharm.D.)
Philadelphia College of Pharmacy and Science, Philadelphia, Pennsylvania
Bachelor of Pharmacy (B.Pharm.)
Université de Montréal, Montréal, Québec

Research experience and interest:
My research is divided into two programs in the area of coronary artery disease:
- Determinant of subendocardial ischemia in a porcine model.
- Evaluation of platelet reactivity and responsiveness to antiplatelet drugs in patients with coronary artery disease.

Articles recently published:

- Lordkipanidzé M, Diodati JG, Schampaert E, Palisaitis DA, Pharand C. Evidence of a pharmacological rebound following discontinuation of clopidogrel therapy in patients with stable coronary artery disease. Platelets 2014; Early online 1-7.

- Crevier F, Binette MC, Girardot D, Laurier C, Vinet J, Mailhot C, Pharand C. Case study of generic competencies assessment. Pharmacy Education 2011; 111-5.

- Lordkipanidzé M, Pharand C, Schampaert E, Palisaitis DA, Diodati JG. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease. Int J Cardiol 2011; 150: 39-44. (IF 3.12)

- Lordkipanidzé M, Diodati JG, Palisaitis DA, Schampaert E, Turgeon J, Pharand C. Genetic determinants of response to aspirin: appraisal of 4 candidate genes. Thromb Res 2011; 128: 47–53. (IF = 2.406)

- Lordkipanidzé M, Pharand C, Nguyen TA, Schampaert E, Diodati JG. Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition. Ther Drug Monit 2008;30:372-8. (IF 3.03)

- Lordkipanidzé M, Pharand C, Nguyen TA, Schampaert E, Palisaitis DA, Diodati JG. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J 2008; 29: 2877-85. (IF 7.924)

- Lordkipanidzé M, Pharand C, Palisaitis DA, Turgeon J, Schampaert E, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702-8. (IF 7.34)

- Lordkipanidzé M, Pharand C, Palisaitis DA, Diodati JG. Aspirin resistance in cardiovascular disease. Pharmacol Therapeut 2006;112:733-43. (IF 8.36)

- de Chantal M, Diodati JG, Nasmith JB, Amyot R, LeBlanc AR, Schampaert E, Pharand C. Progressive epicardial coronary blood flow reduction fails to produce ST-segment depression at normal heart rate. Am J Physiol 2006; 291:2889-96. (IF 3.56)

- Nguyen TA, Diodati J, Pharand C. Response to clopidogrel: is there a resistance phenomenon?. J Am Coll Cardiol 2005;45:1157-64.

Jennifer Pickering
BScPhm, ACPR
Current Position(s):
Clinical Pharmacist- Cardiac and Vascular Program, Coronary Care Unit and Heart Investigation Unit (cath lab)

Practice Site:
Hamilton Health Sciences - Hamilton General Hospital

Practice Expertise and Interests :
Acute Care Cardiology

Email: pickering@hhsc.ca
Ann Thompson
BScPharm, PharmD, ACPR
Current Position(s):
Director, Experiential Education, and Clinical Associate Professor, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB

Practice Site :
Hypertension Clinic, Kaye Edmonton Clinic, Edmonton, AB

Practice Expertise and Interests :
- Management of hypertension and dyslipidemia
- Experiential education of students

Email: athompson@ualberta.ca
Education:
Non-traditional PharmD, University of Colorado, 2011
Accredited Canadian Pharmacy Residency, Queen Elizabeth II Health Science Center, Halifax, Nova Scotia, 1998
BScPharm, Dalhousie University, Halifax, Nova Scotia, 1997

Committees:
- Chair, Pharmacy Experiential Programs of Canada
- Member of Hypertension Canada and the Canadian Cardiovascular Society
- Chair-Elect (2008-2009), Banff Western Conference, Canadian Society of Hospital Pharmacists

Published papers

- McAlister FA, Grover S, Padwal RS, Youngson EY, Fradette M, Thompson A, Buck B, Dean N, Tsuyuki R, Shuaib A, Majumdar SR. Case management reduces global vascular risk after stroke: Secondary results from the The preventing recurrent vascular events and neurological worsening through intensive case-management reandomized controlled trial. Am Heart J 2014;168:924-30.

- McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, Dean N, Bakal JA, Tsuyuki R, Grover SA, Shuaib A. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ 2014;186:577-84.

- Thompson A, Koshman S. Should all high-risk patients receive acetylsalicyclic acid 81 mg daily for primary prevention of cardiovascular disease? The “Pro” side. Can J Hosp Pharm 2012;65(2):148-50.

- Thompson AE, Poole LK, Foisy MM, Lindblad AJ, Druteika DP, Hughes CA. Development of an on-line module for precepting the patient care process. Poster presentation. Association of Faculties of Pharmacy of Canada Annual Conference, Quebec City, QC, June 4-7, 2012.

- Leung TS, Fradette M, Thompson A, Koshman SL. Dabigatran in atrial fibrillation: new kid on the block. Can Pharm J 2012;145(2):83-8.

- Grieve K, Koshman SL, Pearson GJ, Semchuk WM, Padwal R, Thompson A. Low-dose ASA use for primary prevention of cardiovascular disease in patients without diabetes: when should you recommend it? A case-based approach. Can Pharm J 2011;144(6):278-87.

- Thompson AE, Greidanus EJ. Development of an interprofessional simulation involving pharmacy students. Poster presentation. Association of Faculties of Pharmacy of Canada Annual Conference, Winnipeg, MB, June 4-7, 2011.

- Hui D, Hamilton P, Thompson A (editors). Drugs and Drugs: A Practical Guide to the Safe Use of Common Drugs in Adults, 4th edition, 2011.

- McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Tsuyuki R, Grover SA, Dean N, Shuaib A. The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrial.gov identifier: NCT00931788]. Implementation Science 2010;5:27 (12 April 2010).

- Thompson A, Semchuk W, Campbell NR, Kaczorowski J, Tsuyuki RT, for the Canadian Hypertension Education Implementation Task Force. Hypertension guidelines for pharmacists: 2009 update. Can Pharm J 2010;143(1):20-27.

- Thompson A, Campbell NC, Cloutier L, Costello J, Dawes M, Hickey J, et al, for the Canadian Hypertension Education Implementation Task Force. Tackling the burden of hypertension in Canada: encouraging collaborative care. Canadian Family Physician 2008 Dec;54:1659-67.

- Chan AHW, Campbell NR, Lewanczuk RZ, Semchuk W, Thompson AE, Tsuyuki RT, for the Canadian Hypertension Education Implementation Task Force. The 2008 Canadian Hypertension Education Program Guidelines for the management of hypertension by pharmacists. Can Pharm J 2008 Nov/Dec;141:In press.

- Pearson GJ, Thompson AE, Semchuk W. 2007 guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists. Can Pharm J 2007;140(6):383-8.

Recent presentations

Thompson AE, Poole LK, Foisy MM, Lindblad AJ, Druteika DP, Hughes CA. Development of an on-line module for precepting the patient care process. Poster presentation. Association of Faculties of Pharmacy of Canada Annual Conference, Quebec City, QC, June 4-7, 2012.

11th Annual Cardiology Update, Hypertension: The Cardio-renal Swansong, Workshop Co-presented with Dr. Peter Hamilton, May 28, 2011, Edmonton, AB

Practical Therapeutics Workshop, 17th Annual Update, Internal Medicine for Primary Care Physicians, April 8, 2011, Edmonton, AB

Putting Prescribing Into Practice - Workshop, Canadian Society of Hospital Pharmacists AB Branch Annual General Meeting, October 14, 2011, Edmonton, AB.

ASA and its Role in the Prevention of Cardiovascular Disease: Debate (with Dr. Sheri Koshman, pro side), Faculty of Pharmacy and Pharmaceutical Sciences Research and Development Day, November 19, 2010, Edmonton, AB

Patient Assessment by the Pharmacist: Beyond Counseling – Monitoring Drug Therapy, International Society of Hypertension, How To Session for Pharmacists, Co-presented with Dr. Bill Semchuk, September 26-30, 2010, Vancouver, BC

Hypertension Update 2010 (Plenary Session), The 10th Annual Contemporary Cardiovascular Therapy Fall Symposium, September 18-19, 2010, Saskatoon, SK

Hypertension Workshop: Patient Assessment and Treatment, The 10th Annual Contemporary Cardiovascular Therapy Fall Symposium, September 18-19, 2010, Saskatoon, SK

How To Measure Blood Pressure and Patient Resources for Teaching Patient Home BP Measurement, West End Primary Care Network, Edmonton, AB, April 22, 2010

2009 Pharmacist Prescribing: Additional Authorization – Demystifying the Process, Keeping Current, Regional video-conferenced presentation, Edmonton, AB, January 9, 2009; repeated April 23 via videoconferencing for (former) David Thompson Health Region.

Stephanie Young
BSc(Pharm), Pharm.D., MSc(Med)
Current Position(s):
Assistant Professor at Memorial University School of Pharmacy

Practice Site:
Family Medicine Clinic, St. John's, NL

Practice Expertise and Interests:
Ambulatory Care, with a focus on anticoagulation management, cardiovascular disease and medication adherence.

Email:swyoung@mun.ca

Member Emeritus

Patrick Robertson
BSP, PharmD
Current Position(s):
Clinical Manager, Pharmacy Services, Saskatoon Health Region, Saskatoon, SK
Assistant Clinical Professor, College of Pharmacy and Nutrition, University of Saskatchewan

Practice Site :
Adult Cardiology, Royal University Hospital

Practice Expertise and Interests:
Acute coronary syndromes
Percutaneous coronary intervention
General Inpatient Cardiology

Email:patrick.robertson@saskatoonhealthregion.ca
Ross T. Tsuyuki
BSc(Pharm), PharmD, MSc, FCSHP, FACC
Current Position(s):
Professor of Medicine (Cardiology) and Director,
EPICORE Centre/COMPRIS
Department of Medicine, Faculty of Medicine and Dentistry,
University of Alberta, Edmonton, AB

Practice Site:
University of Alberta Hospital

Practice Expertise and Interests:
Outpatient heart failure management (Heart Function Clinic, UAH)
Hypertension Guidelines

Research Interests:
Cardiovascular Clinical Trials (heart failure and hypertension)
Outcomes Research
Clinical Research Support (EPICORE Centre)
Pharmacy Practice Research (COMPRIS)

Email:ross.tsuyuki@ualberta.ca
See also: www.epicore.ualberta.ca
All Content and Information Copyright. © 2009 | Web Design by: Backstreet Communications